Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald S Baim

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Circulation|January 24, 2008
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patientsAlanna Coolong, Donald S Baim, Richard E Kuntz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 10, 2005
Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distributionRoger J Laham, Mark Post, Mehrdad Rezaee, et al.
Circulation|May 23, 2007
Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantationGregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
The American Journal of Cardiology|October 7, 2004
Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study)Donald S Baim, Greg Braden, Richard Heuser, et al.
American Heart Journal|November 19, 2011
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-siteLaura Mauri, Sharon-Lise T Normand, Michael Pencina, et al.
Journal of the American College of Cardiology|December 31, 2002
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trialsDonald E Cutlip, Manish S Chauhan, Donald S Baim, et al.
Circulation|July 1, 2004
Medical device development: from prototype to regulatory approvalAaron V Kaplan, Donald S Baim, John J Smith, et al.
Journal of the American College of Cardiology|November 3, 2004
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trialDavid J Cohen, Sabina A Murphy, Donald S Baim, et al.
The American Journal of Cardiology|December 23, 2008
Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary arteryJack L Martin, Stephen G Ellis, Antonio Colombo, et al.
The American Journal of Cardiology|March 31, 2009
One-year outcomes from the TAXUS express stent versus cypher stentManuel Mayor, Amir Z Malik, Robert J Minor, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Circulation|January 24, 2008
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patientsAlanna Coolong, Donald S Baim, Richard E Kuntz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 10, 2005
Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distributionRoger J Laham, Mark Post, Mehrdad Rezaee, et al.
Circulation|May 23, 2007
Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantationGregg W Stone, Stephen G Ellis, Antonio Colombo, et al.
The American Journal of Cardiology|October 7, 2004
Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study)Donald S Baim, Greg Braden, Richard Heuser, et al.
American Heart Journal|November 19, 2011
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-siteLaura Mauri, Sharon-Lise T Normand, Michael Pencina, et al.
Journal of the American College of Cardiology|December 31, 2002
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trialsDonald E Cutlip, Manish S Chauhan, Donald S Baim, et al.
Circulation|July 1, 2004
Medical device development: from prototype to regulatory approvalAaron V Kaplan, Donald S Baim, John J Smith, et al.
Journal of the American College of Cardiology|November 3, 2004
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trialDavid J Cohen, Sabina A Murphy, Donald S Baim, et al.
The American Journal of Cardiology|December 23, 2008
Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary arteryJack L Martin, Stephen G Ellis, Antonio Colombo, et al.
The American Journal of Cardiology|March 31, 2009
One-year outcomes from the TAXUS express stent versus cypher stentManuel Mayor, Amir Z Malik, Robert J Minor, et al.
Pageof 7